Research Article
DAP10 Predicted the Outcome of Pediatric B-Cell Acute Lymphoblastic Leukemia and Was Associated with the T-Cell Exhaustion
Table 2
Clinical data of the two groups divided by the RNA level of DAP10.
| | | DAP10 high | DAP10 low | |
| | WBC count | 62.4 ± 13.9 | 43.5 ± 7.2 | 0.232 | | WBC >50 | 41.7% (15/36) | 31.1% (19/61) | 0.294 | | Age | 7.3 ± 0.8 | 7.6 ± 0.6 | 0.753 | | Age ≥10 | 30.6% (11/36) | 34.4% (21/61) | 0.695 | | BCR-ABL1 | 2.8% (1/36) | 3.3% (2/61) | 1.000 | | CNS3 at diagnosis | 8.3% (3/36) | 0.0% (0/61) | 0.048 | | High risk | 58.3% (21/36) | 60.7% (34/61) | 0.803 | | Relapse | 55.6% (20/36) | 82.0% (50/61) | 0.005 | | Tri 4/10 | 21.2% (7/33) | 5.6% (3/54) | 0.038 | | TEL/AML1 | 11.1% (3/27) | 11.8% (6/51) | 1.000 | | TCF3/PBX1 | 0.0% (0/27) | 14.3% (7/49) | 0.046 |
|
|
For quantitative data, the results were presented as mean ± SEM; for qualitative data, the results were presented as percentage (positive/all).
|
